3-4 mn doses of Oxford’s Covid-19 vaccine to be ready by Dec: Serum Institute

Serum Institute of India (SII) has said the company is going to produce 3 to 4 million doses of the experimental Covid-19 vaccine candidate developed by Oxford University and AstraZeneca by December this year.Adar Poonawalla, SII’s chief executive officer, said Covishield is the first Covid-19 vaccine they hope to launch if the trials are successful both in the UK and in India.SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its AstraZeneca to manufacture the vaccine once it gets ready.Click here for full Covid-19 coverageThe vaccine from AstraZeneca and Britain’s University of Oxford prompted no serious side effects and elicited antibody and T-cell immune responses with the strongest response seen in people who received two doses, according to trial results published in The Lancet medical journal on Monday.Poonawalla said they will start the trials of the Covid-19 vaccine candidate by the end of August on up to 5,000 Indian volunteers after getting the necessary nods and launch the vaccine by June next year if all goes well.“We will be going for large scale manufacturing in mid-August-early-August… By the end of this year, we should be able to produce 3 to 4 million doses come end of… Read full this story

3-4 mn doses of Oxford’s Covid-19 vaccine to be ready by Dec: Serum Institute have 277 words, post on m.hindustantimes.com at July 22, 2020. This is cached page on CHUTEU. If you want remove this page, please contact us.